Ambulatory care sensitive conditions with high prevalence and interdisciplinary treatment I20, I25, I21, I22, I23, I24 I50, I05, I06, I07, I09, I08, I49, I48, I67, I70, I73, I78, I80, I83, I86, I87, I95, R00, I42, I74, J20, J21, J22, J40, J41, J42, J43,J44, J47,F10, F11, M42, M47, M53, M54, M50, M51,I10-I15, K52, K57, K58, K59,A00 - A09,J10, J11, J13, J14, J15, J16, J18, J12, H66, J01-J03, J06, J31, J32, J35, H65, H73, J04, R07.0,F32, F33,E10, E11, E13, E14, E16,M17 I20-I25 I50 I05-I09 I48
Conditions
Interventions
Group 1: Receipt of feedback to indicators for the treatment of the above mentioned diseases, invitation to network meetings
Group 2: Treatment as usual
Sponsors
Technische Universität München, Lehrstuhl für Gesundheitsökonomie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: A total of 6.481 physicians which are part of one of the 100 intervention networks are recruited. The physician networks were constructed based on physician-patient visits based on routine data of patients with the above mentioned diseases. Networks were cluster-randomized based on region, rural/urban area, size of the network. Networks: consisting of 20-120 physicians, working in one of the 4 physician association regions. 100 intervention, 100 controllnetworks Physicians: Identified in an intervention / control network, practicing in one of the 4 defined regions Patients: Insurees in one of the participating insurances (AOK Rheinland-Hamburg / AOK Nordwest / TK), living in the intervention region, at least one diagnosis of the above mentioned ambulatory care sensitive conditions
Exclusion criteria
Exclusion criteria: Participants: patients in a dialysis treatment Physicians: Pediatricians incl. Pediatric disciplines, laboratory medicine, microbiology, virology and infection epidemiology, maxillofacial surgeons, pathology, radiology, neuroradiology, radiation therapy, transfusion medicine, child and adolescent psychotherapist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ambulatory care senstive hospitalizations due to the above mentioned conditions These Hospital cases are derived from routine data of two Major Health insurance funds prior to the Intervention as well as until end of 2019. Additionally, the year 2021 (follow-up time) will be compared. Cases of ambulatory care sensitive conditions are analysed using multilevel models and an Intention to treat approach. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are indicators of the proportion of guideline-based treatments and acceptance among service providers. Data: Indicators of Guideline-based Treatments are derived in Routine data of the two Major Health insurance funds. Data is available Prior to the intervetion and during the Intervention until the end of 2019. Acceptance among providers is analysed based on a process Evaluation encluding interviews and questinnaires. Moderators receive questionnaires in the moderator Training. Furthermore, questionnaires are filled out by Moderators and participants of the Network Meetings after the Network Meetings. Additionally, Moderators and participants of the Network Meetings are interviewed to assess their acceptance of the Meetings. | — |
Countries
Germany
Contacts
Public ContactStefan Wilm
Direktor des Instituts für Allgemeinmedizin (ifam)
Outcome results
None listed